Next Article in Journal
Short Communication: Rotavirus Group A Occurrence in Rural Water Source Samples in a Midwest Region State of Brazil, Comparing Wet and Dry Seasons
Previous Article in Journal
Genomic Characterization of Phage ZP3 and Its Endolysin LysZP with Antimicrobial Potential against Xanthomonas oryzae pv. oryzae
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Brief Report

Bovine Highly Pathogenic Avian Influenza Virus Stability and Inactivation in the Milk Byproduct Lactose

1
Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA
2
Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA
*
Author to whom correspondence should be addressed.
Viruses 2024, 16(9), 1451; https://doi.org/10.3390/v16091451
Submission received: 20 August 2024 / Revised: 9 September 2024 / Accepted: 10 September 2024 / Published: 12 September 2024
(This article belongs to the Special Issue Bovine Influenza)

Abstract

:
The recent incursion of highly pathogenic influenza viruses into dairy cattle opens new insights for influenza virus ecology and its interspecies transmission and may have a significant impact on public health and agriculture. The aim of this study was to determine the stability of a bovine highly pathogenic avian influenza H5N1 virus isolate in the milk byproduct lactose and to evaluate two inactivation methods using industrial procedures. The bovine isolate of the highly pathogenic avian influenza H5N1 virus was stable for 14 days in a concentrated lactose solution under refrigerated conditions. Heat or citric acid treatments successfully inactivated the virus in lactose. This study highlights the persistence of HPAIV in lactose and its efficient inactivation under industrial standards.

1. Introduction

Recently, clade 2.3.4.4b viruses were detected in dairy cattle populations in the United States [1,2]. Infected cattle exhibited reduced appetite, fever, mild respiratory symptoms, reduced milk production, and changes in milk quality [3,4]. High levels of virus shedding in milk have been detected in affected cows, with virus titers ranging from 104 to 108.8 TCID50/mL [3]. In contrast, an experimental infection of calves with a bovine H5N1 isolate via intra-nasal and oral routes resulted in moderate virus shedding with no obvious clinical signs [4]. It is presumed that a single introduction from wild birds to cattle occurred, and subsequently, the movement of subclinical cattle played a significant role in its spread to multiple sites [5]. Four human infections with HPAI H5N1 viruses following exposure to dairy cattle have been reported so far [6,7]. Given the high titer of the virus in milk and the potential for H5N1 transmission via raw milk and its byproducts to humans and agricultural animals, it is essential to develop appropriate processes to inactivate the bovine H5N1 virus in these substrates to mitigate the risk of transmission. Current knowledge and techniques have focused on the pasteurization of milk, which is widespread within the dairy industry and has been shown to be effective for HPAI viruses [8,9,10]. The consumption of contaminated materials is presumably considered a major route of HPAI infection in pet and wild mammals [11]. Therefore, additional research is needed to validate inactivation processes in milk and its byproducts, such as dried whey, whey permeate, and lactose, which are used for animal nutrition in agriculture. Therefore, this study aimed to determine the stability of a bovine H5N1 isolate in the milk byproduct lactose and to evaluate two inactivation methods using industrial procedures.

2. Materials and Methods

The bovine isolate of HPAI H5N1 clade 2.3.4.4b, isolate A/Cattle/Texas/063224-24-1/2024 [3], was propagated and titrated on MDCK cells. The virus stock was mixed with a concentrated lactose solution at 1:10 dilution, and 1 mL of contaminated lactose was incubated at refrigerated temperatures (4.4 °C to 5.6 °C) and titrated on MDCK cells.
For inactivation, virus-spiked lactose at a 1:10 dilution was subjected to heat or citric acid treatments. A total of 1 mL of the H5N1-spiked lactose was incubated at 63, 66, or 99 °C for up to 30 min and cooled down on ice water for at least 30 min. The temp 63 °C for 30 min was chosen since it is used by the food industry for pasteurization. Other temperatures were chosen to evaluate the efficacy of elevated temperatures and shorter time periods. For citric acid treatment, 1 mL of the H5N1-spiked lactose was mixed with 1 mL of different levels of citric acid and incubated at refrigerated temperatures (4.4 °C to 5.6 °C). After a defined incubation time, the sample was neutralized by adding 1N NaOH. All samples were titrated on MDCK cells, and the presence of infectious viruses were visualized by an immunofluorescence assay.

3. Results

The bovine H5N1 virus was rather stable in lactose at a refrigerated temperature, and there was only a 1-log reduction after incubation for 14 days (Figure 1). Heat treatment at 63 °C for 5 min resulted in 3-log reduction in both high- and low-dose samples, and all samples were virus-negative at 15 and 30 min (Table 1). No infectious virus was isolated after heat treatment at 66 °C and 99 °C for a minimum of 5 min. Next, we investigated the effect of citric acid treatment on virus inactivation in the concentrated lactose solution. In high-dose samples, low levels of the virus were still present after treatment with 0.2% and 0.4% citric acid for up to 1 h, but the virus was inactivated after 0.6% citric acid treatment. For low-dose samples, 0.2% and 0.4% citric acid treatment successfully inactivated H5N1 within 20 min, and 0.1% treatment was effective at inactivating the virus after 40 min contact time (Table 1).

4. Discussion

Our findings highlight bovine H5N1 virus survival in concentrated lactose solution for up to 14 days at holding temperature and emphasize its successful inactivation by pasteurization (63 °C) and citric acid treatment. In this study, samples with high virus titers are consistent with the observed range of virus titers in milk from infected cows [3,4], and the low-titer samples would theoretically be possible if milk from infected animals is diluted with milk from non-infected animals. Thus, the viral titers used in the current experiment are representative of possible virus levels in milk and its coproducts. In previous studies, heat treatment at 72 °C for 15 s completely inactivated the virus in spiked raw milk collected from healthy dairy cattle [12], but the virus was still viable after 72 °C for 30 s in H5-positive milk from infected animals [9]. Although the present study evaluated the inactivation of the virus in the spiked samples, experiments using milk byproducts derived from H5N1-contaminated milk would provide additional insights into the efficacy of inactivation procedures of milk byproducts.
This is the first study to investigate the inactivation of a bovine HPAI H5N1 virus in the milk coproduct, concentrated lactose, which is frequently used as a feed ingredient for agricultural animals including pigs as well as for other purposes. In summary, H5N1-contaminated milk byproducts might pose a risk to animal health if consumed untreated. This study provides insights on the persistence of bovine HPAIV in dairy byproducts and effective inactivation strategies under industrial standards.

Author Contributions

Conceptualization, T.K., J.T.G. and J.A.R.; methodology, T.K. and J.T.G.; investigation, T.K., E.L.L., M.N., N.N.G. and I.M.; writing—original draft preparation, T.K.; writing—review and editing, T.K., J.T.G., D.G.D. and J.A.R.; supervision, J.A.R.; project administration, J.T.G. and J.A.R.; funding acquisition, J.T.G. and J.A.R. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by the National Bio and Agro-Defense Facility (NBAF) Transition Fund from the State of Kansas, the MCB Core of the Center on Emerging and Zoonotic Infectious Diseases (CEZID) of the National Institutes of General Medical Sciences under award number P20GM130448, and the NIAID-supported Center of Excellence for Influenza Research and Response (CEIRR) under contract number 75N93021C00016.

Institutional Review Board Statement

The experiments were approved and performed under the Kansas State University (KSU) Institutional Biosafety Committee (IBC, Protocol #: 1758).

Informed Consent Statement

Not applicable.

Data Availability Statement

Raw data are available upon request.

Conflicts of Interest

The J.A.R. laboratory received support from Tonix Pharmaceuticals, Xing Technologies, and Zoetis outside of the reported work. J.A.R. is the inventor on patents and patent applications on the use of antivirals and vaccines for the treatment and prevention of virus infections, owned by Kansas State University. The other authors declare no competing interests.

References

  1. Animal and Plant Health Inspection Service. Detections of Highly Pathogenic Avian Influenza (HPAI) in Livestock; Animal & Plant Health Inspection Service: Riverdale Park, MD, USA, 2024. [Google Scholar]
  2. Singh, G.; Trujillo, J.D.; McDowell, C.D.; Matias-Ferreyra, F.; Kafle, S.; Kwon, T.; Gaudreault, N.N.; Fitz, I.; Noll, L.; Morozov, I.; et al. Detection and characterization of H5N1 HPAIV in environmental samples from a dairy farm. Virus Genes 2024, 60, 517–527. [Google Scholar] [CrossRef] [PubMed]
  3. Caserta, L.C.; Frye, E.A.; Butt, S.L.; Laverack, M.; Nooruzzaman, M.; Covaleda, L.M.; Thompson, A.C.; Koscielny, M.P.; Cronk, B.; Johnson, A.; et al. Spillover of highly pathogenic avian influenza H5N1 virus to dairy cattle. Nature 2024. [Google Scholar] [CrossRef] [PubMed]
  4. Halwe, N.J.; Cool, K.; Breithaupt, A.; Schon, J.; Trujillo, J.D.; Nooruzzaman, M.; Kwon, T.; Ahrens, A.K.; Britzke, T.; McDowell, C.D.; et al. Outcome of H5N1 clade 2.3.4.4b virus infection in calves and lactating cows. bioRxiv 2024. [Google Scholar] [CrossRef]
  5. Nguyen, T.-Q.; Hutter, C.; Markin, A.; Thomas, M.; Lantz, K.; Killian, M.L.; Janzen, G.M.; Vijendran, S.; Wagle, S.; Inderski, B.; et al. Emergence and interstate spread of highly pathogenic avian influenza A(H5N1) in dairy cattle. bioRxiv 2024. [Google Scholar] [CrossRef]
  6. Uyeki, T.M.; Milton, S.; Hamid, C.A.; Webb, C.R.; Presley, S.M.; Shetty, V.; Rollo, S.N.; Martinez, D.L.; Rai, S.; Gonzales, E.R.; et al. Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker. N. Engl. J. Med. 2024, 390, 2028–2029. [Google Scholar] [CrossRef] [PubMed]
  7. Centers for Disease Control and Prevention. CDC Reports Fourth Human Case of H5 Bird Flu Tied to Dairy Cow Outbreak; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2024. [Google Scholar]
  8. Kaiser, F.; Morris, D.H.; Wickenhagen, A.; Mukesh, R.; Gallogly, S.; Yinda, K.C.; de Wit, E.; Lloyd-Smith, J.O.; Munster, V.J. Inactivation of Avian Influenza A(H5N1) Virus in Raw Milk at 63 °C and 72 °C. N. Engl. J. Med. 2024, 391, 90–92. [Google Scholar] [CrossRef] [PubMed]
  9. Guan, L.; Eisfeld, A.J.; Pattinson, D.; Gu, C.; Biswas, A.; Maemura, T.; Trifkovic, S.; Babujee, L.; Presler, R., Jr.; Dahn, R.; et al. Cow’s Milk Containing Avian Influenza A(H5N1) Virus—Heat Inactivation and Infectivity in Mice. N. Engl. J. Med. 2024, 391, 87–90. [Google Scholar] [CrossRef] [PubMed]
  10. Spackman, E.; Jones, D.R.; McCoig, A.M.; Colonius, T.J.; Goraichuk, I.V.; Suarez, D.L. Characterization of highly pathogenic avian influenza virus in retail dairy products in the US. J. Virol. 2024, 98, e0088124. [Google Scholar] [CrossRef] [PubMed]
  11. Adlhoch, C.; Fusaro, A.; Gonzales, J.L.; Kuiken, T.; Melidou, A.; Mirinaviciute, G.; Niqueux, E.; Stahl, K.; Staubach, C.; Terregino, C.; et al. Avian influenza overview April–June 2023. EFSA J. 2023, 21, e08191. [Google Scholar] [PubMed]
  12. Cui, P.; Zhuang, Y.; Zhang, Y.; Chen, L.; Chen, P.; Li, J.; Feng, L.; Chen, Q.; Meng, F.; Yang, H.; et al. Does pasteurization inactivate bird flu virus in milk? Emerg. Microbes Infect. 2024, 13, 2364732. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The stability of the bovine isolate of HPAI H5N1 clade 2.3.4.4b in a concentrated lactose solution. The virus was mixed with whole milk and lactose at 1:10 dilution and incubated at a refrigerated temperature. At each time point, the samples were titrated on MDCK cells. Dash line represents the limit of detection, 4.64 TCID50/mL.
Figure 1. The stability of the bovine isolate of HPAI H5N1 clade 2.3.4.4b in a concentrated lactose solution. The virus was mixed with whole milk and lactose at 1:10 dilution and incubated at a refrigerated temperature. At each time point, the samples were titrated on MDCK cells. Dash line represents the limit of detection, 4.64 TCID50/mL.
Viruses 16 01451 g001
Table 1. Inactivation of the bovine isolate of HPAI H5N1 clade 2.3.4.4b in a concentrated lactose solution.
Table 1. Inactivation of the bovine isolate of HPAI H5N1 clade 2.3.4.4b in a concentrated lactose solution.
TreatmentVirus DoseConditionTime and Virus Titer 1 (TCID50/mL)
0 min5 min15 min30 min
HeatHigh63 °C3.59 × 1054.64 × 102NegativeNegative
66 °CNegativeNegativeNegative
99 °CNegativeNegativeNegative
Low63 °C1.29 × 1033.78 × 100NegativeNegative
Acidulant level0 min20 min40 min60 min
Citric acidHigh0.2%2.15 × 1057.74 × 1005.99 × 1006.14 × 100
0.4%3.78 × 1003.68 × 1004.64 × 100
0.6%NegativeNegativeNegative
LowUntreated1.29 × 1031.00 × 1031.29 × 1031.29 × 103
0.1%3.68 × 100NegativeNegative
0.2%NegativeNegativeNegative
0.4%NegativeNegativeNegative
1 The limit of detection of this assay was 4.64 TCID50/mL.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kwon, T.; Gebhardt, J.T.; Lyoo, E.L.; Nooruzzaman, M.; Gaudreault, N.N.; Morozov, I.; Diel, D.G.; Richt, J.A. Bovine Highly Pathogenic Avian Influenza Virus Stability and Inactivation in the Milk Byproduct Lactose. Viruses 2024, 16, 1451. https://doi.org/10.3390/v16091451

AMA Style

Kwon T, Gebhardt JT, Lyoo EL, Nooruzzaman M, Gaudreault NN, Morozov I, Diel DG, Richt JA. Bovine Highly Pathogenic Avian Influenza Virus Stability and Inactivation in the Milk Byproduct Lactose. Viruses. 2024; 16(9):1451. https://doi.org/10.3390/v16091451

Chicago/Turabian Style

Kwon, Taeyong, Jordan T. Gebhardt, Eu Lim Lyoo, Mohammed Nooruzzaman, Natasha N. Gaudreault, Igor Morozov, Diego G. Diel, and Juergen A. Richt. 2024. "Bovine Highly Pathogenic Avian Influenza Virus Stability and Inactivation in the Milk Byproduct Lactose" Viruses 16, no. 9: 1451. https://doi.org/10.3390/v16091451

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop